MAP2K2

There are 9 papers on MAP2K2 in aging research: 1 observational study in people, 1 in animals, 4 in cells. The newest story, Oct 30, 2026: “Human colorectal cancer cells become more vulnerable to two drugs”.

Gene

9 papers study it1 finding

HGNCNCBI GeneTaxon

1 new paper in 30 daysSee all 9 papers on MAP2K2

At a glance

50 trials, 10 with no results posted.

Cells, worms or flies, mice and humans: nothing yet.
  • 50 trials, 10 with no results posted
  • 50 of 50 trials sponsored by developers of drugs aimed at it
  • Humans1
  • Animals1
  • Cells4
  • In silico3

Associations

1

Triple-negative breast cancer

mixedin silico1

1 study
  1. MAP2K2 is associated with triple-negative breast cancer in silico (compared with overall breast cancer, with opposite association signs).

    In silicocompared with overall breast cancer, with opposite association signs

More on Triple-negative breast cancer

Latest

Dec 2025: 1Jan 2026: 0Feb 2026: 0Mar 2026: 1Apr 2026: 0May 2026: 0Jun 2026: 1Jul 2026: 1Aug 2026: 0Sep 2026: 0Oct 2026: 1Nov 2026: 05 papers in 12 months
Aging and Disease

Human colorectal cancer cells become more vulnerable to two drugs

In lab experiments, activating an odor-sensing receptor induced a state resembling senescence, when cells stop dividing, and increased cancer cells’ susceptibility to two…In lab experiments, activating an odor-sensing receptor induced a state resembling senescence, when cells stop dividing, and increased cancer cells’ susceptibility to two drugs.

Human cell studyColorectal cancer